<i>SMPD1</i> mutations, activity, and α‐synuclein accumulation in Parkinson's diseaseRoy N. Alcalay, Ziv Gan‐Or, Victoria Mallett et al.|Movement Disorders|2019Cited by 117
Candidate Genetic Modifiers for Breast and Ovarian Cancer Risk in <i>BRCA1</i> and <i>BRCA2</i> Mutation CarriersPaolo Peterlongo, Javier Benı́tez, Matti A. Rookus et al.|Cancer Epidemiology Biomarkers & Prevention|2014Cited by 25
De novo variants in FRYL are associated with developmental delay, intellectual disability, and dysmorphic featuresXueyang Pan, Hugo J. Bellen, Alice M. Tao et al.|The American Journal of Human Genetics|2024Cited by 11
Genetic and Phenotypic Features of the Five Known Polyaminopathies: A Critical Narrative ReviewElizabeth VanSickle, Caleb Bupp, Sara M. Sarasua et al.|American Journal of Medical Genetics Part A|2025Cited by 1
Clinical and neurogenetic characterisation of autosomal recessive RBL2-associated progressive neurodevelopmental disorderGabriel Aughey, Henry Houlden, Elisa Calì et al.|medRxiv|2024Cited by 0